KPV shows anti-inflammatory properties in colitis models through different mechanisms than mesalamine, potentially offering complementary benefits. While mesalamine is an established pharmaceutical with extensive clinical data, KPV research is primarily pre-clinical. Some studies suggest KPV may have fewer systemic side effects, but it should not replace proven therapies without medical supervision.
KPV colitis research